January 2024
1. WEBER JS, Carlino MS, Khattak A, Meniawy T, et al
   Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.
   Lancet. 2024 Jan 18:S0140-6736(23)02268-7. doi: 10.1016/S0140-6736(23)02268.
   

   >> Share

   
   July 2023
2. LONG GV, Swetter SM, Menzies AM, Gershenwald JE, et al
   Cutaneous melanoma.
   Lancet. 2023 Jul 24:S0140-6736(23)00821-8. doi: 10.1016/S0140-6736(23)00821.
   

   >> Share

   
   February 2023
3. CORREA-SELM L, Hanlon KL, Grichnik JM
   Differentiating activated Langerhans cells and dendritic melanocytes using reflectance confocal microscopy: the limitations of diagnosing melanoma in vivo.
   Lancet. 2023;401:590.
   

   >> Share

   
   September 2022
4. LIVINGSTONE E, Zimmer L, Hassel JC, Fluck M, et al
   Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial.
   Lancet. 2022 Sep 9. pii: S0140-6736(22)01654.
   

   >> Share

   
   
5. SMITHY JW, Postow MA
   Adjuvant checkpoint blockade following complete local therapy for melanoma metastases.
   Lancet. 2022 Sep 9. pii: S0140-6736(22)01748.
   

   >> Share

   
   August 2022
6. HINDIE E
   Adjuvant therapy in stage IIB and IIC melanoma: is sentinel biopsy needed?
   Lancet. 2022;400:559.
   

   >> Share

   
   
7. LUKE JJ, Ibrahim N, Eggermont AM
   Adjuvant therapy in stage IIB and IIC melanoma: is sentinel biopsy needed? - Authors' reply.
   Lancet. 2022;400:559-560.
   

   >> Share

   
   April 2022
8. TCHERNEV G, Chokoeva AA
   Melanoma in a Chinese dragon tattoo.
   Lancet. 2022;399:e37.
   

   >> Share

   
   March 2022
9. LUKE JJ, Rutkowski P, Queirolo P, Del Vecchio M, et al
   Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial.
   Lancet. 2022 Mar 31. pii: S0140-6736(22)00562.
   

   >> Share

   
   September 2021
10. CARLINO MS, Larkin J, Long GV
    Immune checkpoint inhibitors in melanoma.
    Lancet. 2021;398:1002-1014.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share